Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Bausch & Lomb Corp publishes a filing, an earnings call transcript or a press release.

Get BLCO alerts

About Andrew Stewart

Bausch & Lomb Corp reported in an 8-K filed April 12, 2023 that Andrew Stewart was appointed President, Ophthalmic Pharmaceuticals, effective April 24, 2023. The proxy statement of Bausch & Lomb Corp reports total compensation of $2,500,253 for Andrew Stewart in fiscal 2025, including a base salary of $629,077. Disclosed compensation is on record for 3 fiscal years. Bausch & Lomb Corp is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Bausch & Lomb Corp includes Thomas J. Appio (CEO and Board Member), Brent Saunders (Chairman), Thomas W. Ross, Sr. (Chairman and Board Member) and 7 others.

“Andrew Stewart will be appointed as the Company’s President, Ophthalmic Pharmaceuticals.”
Bausch & Lomb Corp Form 8-K, filed April 12, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Bausch & Lomb Corp

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Bausch & Lomb Corp (BLCO) $629,077 $2,500,253
2024 Bausch & Lomb Corp (BLCO) $616,269 $4,082,270
2023 Bausch & Lomb Corp (BLCO) $415,385 $1,933,266

Recent activity